New search | Conferencedetail
Print view
 
 

Targeted Protein Degradation Summit

evvnt Platform / evvnt
Conference themes
As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 is a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class.

Focus on understanding the selectivity and speed of binding, improve the rationale design of bifunctional molecules and overcome critical chemistry challenges.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Craig Crews (Yale University), Alexandra Glucksmann (Cedilla Therapeutics), John Houston (Arvinas), Laurent Audoly (Kymera Therapeutics), John Harling (GSK), Brian Jones (Cedilla Therapeutics)
 

Enquiries and Registration:

https://go.evvnt.com/259077-1?pid=4832
Mr. Hanson Wade
 
Categories
Pharmacology and Toxicology
Languages
English
Congress fees
USD 3.997,00
(USD 599.0 - USD 3997.0)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Ärztekammer für WienSwiss Tropical and Public Health InstituteÖsterreichische Akademie der ÄrzteHilfswerk AustriaÖsterreichische Gesellschaft für Public HealthÄrzte der WeltÖsterreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.

Facebook

Give us your professional opinion

Start survey

Start survey